Global Antipsychotic Drugs Market 2023-2029

April 2023 | 79 pages | ID: GCF64E656C92EN
Gen Consulting Company

Abstracts

Antipsychotic drugs, also known as neuroleptics, are a class of medications used to treat mental health disorders such as schizophrenia, bipolar disorder, and severe depression. They work by altering the levels of certain chemicals in the brain, such as dopamine and serotonin, which are involved in regulating mood, behavior, and perception. The global antipsychotic drugs market is projected to rise by USD 2.0 billion by 2029, according to the latest market study results. It is anticipated to expand at a CAGR of 2.2 percent during the forecast period. The market growth is driven by several factors, including the increasing prevalence of mental health disorders such as schizophrenia, bipolar disorder, and depression, and the growing awareness of the importance of early diagnosis and treatment. In addition, the development of new and more effective antipsychotic drugs is expected to drive market growth in the coming years.The market growth is driven by several factors, including the increasing prevalence of mental health disorders such as schizophrenia, bipolar disorder, and depression, and the growing awareness of the importance of early diagnosis and treatment. In addition, the development of new and more effective antipsychotic drugs is expected to drive market growth in the coming years.

The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global antipsychotic drugs market. It presents a quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities. The report also identifies top segments for opportunities and strategies based on market trends and leading competitors’ approaches.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the mechanism of action, indication, and region. The global market for antipsychotic drugs can be segmented by mechanism of action: D2/5HT2A antagonist, D2 partial agonist, others. According to the research, the D2/5HT2A antagonist segment had the largest share in the global antipsychotic drugs market. Antipsychotic drugs market is further segmented by indication: schizophrenia, bipolar disorder, major depressive disorder, others. In 2022, the schizophrenia segment made up the largest share of revenue generated by the antipsychotic drugs market. Based on region, the antipsychotic drugs market is segmented into: Asia-Pacific, Europe, North America, Rest of the World (RoW). Among these, North America was accounted for the highest revenue generator in 2022.

Market Segmentation

By mechanism of action: D2/5HT2A antagonist, D2 partial agonist, others

By indication: schizophrenia, bipolar disorder, major depressive disorder, others

By region: Asia-Pacific, Europe, North America, Rest of the World (RoW)

The report explores the recent developments and profiles of key vendors in the Global Antipsychotic Drugs Market, including Allergan plc, AstraZeneca plc, Dr. Reddy's Laboratories Ltd., Eli Lilly and Company, H. Lundbeck A/S, Janssen Pharmaceuticals, Inc. (Johnson & Johnson), Mylan N.V., Otsuka Holdings Co., Ltd., Sumitomo Dainippon Pharma Co., Ltd., among others. In this report, key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Scope of the Report

• To analyze and forecast the market size of the global antipsychotic drugs market.
• To classify and forecast the global antipsychotic drugs market based on mechanism of action, indication, region.
• To identify drivers and challenges for the global antipsychotic drugs market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global antipsychotic drugs market.
• To identify and analyze the profile of leading players operating in the global antipsychotic drugs market.

Why Choose This Report

• Gain a reliable outlook of the global antipsychotic drugs market forecasts from 2023 to 2029 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION

Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience

PART 2. METHODOLOGY

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

Introduction
Drivers
Restraints

PART 5. MARKET BREAKDOWN BY MECHANISM OF ACTION

D2/5HT2A antagonist
D2 partial agonist
Others

PART 6. MARKET BREAKDOWN BY INDICATION

Schizophrenia
Bipolar disorder
Major depressive disorder
Others

PART 7. MARKET BREAKDOWN BY REGION

Asia-Pacific
Europe
North America
Rest of the World (RoW)

PART 8. KEY COMPANIES

Allergan plc
AstraZeneca plc
Dr. Reddy's Laboratories Ltd.
Eli Lilly and Company
H. Lundbeck A/S
Janssen Pharmaceuticals, Inc. (Johnson & Johnson)
Mylan N.V.
Otsuka Holdings Co., Ltd.
Sumitomo Dainippon Pharma Co., Ltd.
DISCLAIMER